Comparing vacuum dressings to standard dressings after surgery for soft tissue sarcoma
Official title: The Effect of INPWT on Wound Complications and Clinical Outcomes Following Lower Extremity Sarcoma Surgery in Patients Treated With Preoperative Radiation Therapy: A Multicentre Randomized Controlled Trial
Run by Ottawa Hospital Research Institute · NCT03175718 · Data updated 2026-11-12
This study is testing if using vacuum dressings instead of standard dressings after surgery can help patients with soft tissue sarcoma heal better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 291 (estimated) |
| Sponsor | Ottawa Hospital Research Institute Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Ottawa, Ontario and 1 other locations) |
| Status | Recruiting |
| Started | February 1, 2022 |
| Main results expected | January 2028 |
| Study ends | January 28, 2028 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT03175718 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with confirmed lower extremity soft tissue sarcoma who are eligible for preoperative radiation therapy followed by limb salvage surgery.
✕Probably not a fit
Patients with benign diseases, prior radiation to the treatment area, or those who cannot achieve primary closure at the time of surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of Incisional Negative Pressure Wound Therapy (INPWT) compared to standard dressings in patients undergoing surgery for lower extremity soft tissue sarcoma after preoperative radiation therapy. A total of 248 patients will be randomly assigned to receive either vacuum dressings or standard dressings post-surgery. The study aims to evaluate differences in wound complications, length of hospital stay, patient quality of life, satisfaction, and functional outcomes over a follow-up period of four months. The trial is being conducted across multiple orthopedic cancer centers in Canada, led by a team from The Ottawa Hospital.
Why it matters
Potential benefit: If successful, this study could significantly reduce wound complications and improve the quality of life for patients undergoing surgery for soft tissue sarcoma.
How similar studies have gone: Previous studies have shown that negative pressure dressings can reduce wound complications, suggesting a promising approach in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age and older and are able to provide written consent. * Patients with lower extremity soft tissue sarcoma confirmed by tissue pathology.Each patient must have local cross sectional imaging (CT or MRI) and a staging CT chest. * Patients eligible for treatment with preoperative radiation therapy followed by limb salvage surgery. * Patients for which a primary closure must be attained at the time of surgery. * Patient must be available for postoperative follow-up at the treating center. Exclusion Criteria: * Patients who are less than 18 years of age. * Patients with a benign disease or with prior radiation to the anatomic region in the remote past (not associated with current treatment radiation plans). * Patients who underwent surgical amputation * Patients in which primary closure was not achieved (including free flaps and split thickness skin grafts). * Patients with a life expectancy less than 120 days. * Patients who have an allergy or sensitivity to adhesive dressings.
Where it's running
-
The Ottawa Hospital
Ottawa, Ontario, Canada Recruiting -
McGill University Health Center
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Joel Werier — Surgeon
- Study coordinator: Yusra K Al-Mosuli
- Email: yalmosuli@ohri.ca
- Phone: 6137378920
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
68Ga-HX01 PET/CT Imaging in Soft Tissue Sarcoma patients
This study tests whether a 68Ga-HX01 injection can help PET/CT imaging better characterize soft tissue sarcoma in adults who have exhausted standard treatments or have no good options.
-
Zemetostat plus Anlotinib for SWI/SNF-deficient Head and Neck Soft Tissue Sarcoma
This trial tests whether zemetostat plus anlotinib can help people with recurrent or metastatic head-and-neck soft tissue sarcoma that has SWI/SNF complex deficiency after standard therapy fails.
-
Entinostat for pediatric soft tissue sarcoma with PAX abnormalities
This study tests entinostat, alone or with chemotherapy, in children whose soft tissue sarcomas have PAX-family gene abnormalities to see if it can help shrink tumors or slow progression.
-
Prophylactic subcutaneous drainage after gynecologic cancer surgery
This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.
-
Methionine-Reduced Diet in Solid Tumors (early-phase)
A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.
-
Preoperative Immunonutrition for bone and soft tissue sarcoma patients
This study tests whether a short course of an oral nutrition supplement before surgery can help patients with bone or soft tissue sarcomas recover better after major tumor-related surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.